STOCK TITAN

[SCHEDULE 13G/A] ELI LILLY & Co Amended Passive Investment Disclosure

Lilly Endowment, Inc. reports beneficial ownership of 91,896,978 shares of Eli Lilly and Company common stock, representing 9.7% of the class as of March 31, 2026.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Lilly Endowment, Inc. reports beneficial ownership of 91,896,978 shares of Eli Lilly and Company common stock, representing 9.7% of the class as of March 31, 2026.

The filing states the 9.7% figure is based on 944,818,881 shares outstanding as of February 25, 2026, and the statement is signed April 20, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





532457108

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of class represented is based on 944,818,881 shares of common stock outstanding as of February 25, 2026 (the most recent date for which such information is publicly available), as reported in the Issuer's definitive proxy statement for its 2026 annual meeting of shareholders. This information is provided as of March 31, 2026.


SCHEDULE 13G



LILLY ENDOWMENT, INC.
Signature:Diane M. Stenson
Name/Title:Vice President and Treasurer
Date:04/20/2026

Keep reading